Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= APOD ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: APOD * **<color #00a2e8>Official Name</color>**: apolipoprotein D * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=347|347]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P05090|P05090]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=APOD&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20APOD|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/107740|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: N/A * **<color #00a2e8>UniProt Summary</color>**: APOD occurs in the macromolecular complex with lecithin- cholesterol acyltransferase. It is probably involved in the transport and binding of bilin. Appears to be able to transport a variety of ligands in a number of different contexts. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |Lipocalin 2| |Lipocalin| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |negative regulation of lipoprotein lipid oxidation| |negative regulation of lipoprotein oxidation| |regulation of lipoprotein lipid oxidation| |regulation of lipoprotein oxidation| |negative regulation of smooth muscle cell-matrix adhesion| |regulation of smooth muscle cell-matrix adhesion| |negative regulation of lipoprotein metabolic process| |negative regulation of T cell migration| |peripheral nervous system axon regeneration| |negative regulation of monocyte chemotactic protein-1 production| |cytosolic ribosome| |negative regulation of protein import into nucleus| |negative regulation of protein import| |negative regulation of platelet-derived growth factor receptor signaling pathway| |regulation of lipoprotein metabolic process| |negative regulation of lymphocyte migration| |regulation of monocyte chemotactic protein-1 production| |negative regulation of cytokine production involved in inflammatory response| |negative regulation of focal adhesion assembly| |negative regulation of chemokine production| |negative regulation of nucleocytoplasmic transport| |negative regulation of adherens junction organization| |regulation of platelet-derived growth factor receptor signaling pathway| |axon regeneration| |negative regulation of cell junction assembly| |neuron projection regeneration| |negative regulation of protein localization to nucleus| |lipid transporter activity| |negative regulation of cell-matrix adhesion| |regulation of cytokine production involved in inflammatory response| |negative regulation of intracellular protein transport| |regulation of T cell migration| |negative regulation of leukocyte migration| |negative regulation of smooth muscle cell proliferation| |response to axon injury| |cholesterol binding| |regulation of protein import into nucleus| |regulation of protein import| |negative regulation of intracellular transport| |regulation of focal adhesion assembly| |regulation of cell-substrate junction assembly| |regulation of lymphocyte migration| |negative regulation of cell-substrate adhesion| |tissue regeneration| |regulation of adherens junction organization| |regulation of chemokine production| |negative regulation of lipid metabolic process| |regulation of cell junction assembly| |regulation of nucleocytoplasmic transport| |negative regulation of cellular protein localization| |glucose metabolic process| |regulation of cell-matrix adhesion| |regulation of protein localization to nucleus| |regulation of smooth muscle cell proliferation| |negative regulation of inflammatory response| |regeneration| |hexose metabolic process| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |response to reactive oxygen species| |regulation of leukocyte migration| |monosaccharide metabolic process| |negative regulation of defense response| |regulation of cell-substrate adhesion| |regulation of intracellular protein transport| |negative regulation of cell migration| |negative regulation of cell adhesion| |negative regulation of cell motility| |negative regulation of cytokine production| |aging| |lipid transport| |negative regulation of cellular component movement| |angiogenesis| |lipid localization| |negative regulation of locomotion| |regulation of inflammatory response| |regulation of intracellular transport| |negative regulation of response to external stimulus| |neuronal cell body| |response to oxidative stress| |developmental growth| |growth| |regulation of lipid metabolic process| |blood vessel morphogenesis| |axon development| |dendrite| |negative regulation of immune system process| |carbohydrate metabolic process| |wound healing| |negative regulation of transport| |blood vessel development| |vasculature development| |cardiovascular system development| |regulation of cellular protein localization| |response to wounding| |tube morphogenesis| |neuron projection development| |negative regulation of cell population proliferation| |regulation of cell adhesion| |regulation of cytokine production| |perinuclear region of cytoplasm| |negative regulation of cellular component organization| |regulation of protein transport| |regulation of peptide transport| |brain development| |regulation of establishment of protein localization| |regulation of defense response| |head development| |neuron development| |tube development| |regulation of cell migration| |circulatory system development| |anatomical structure formation involved in morphogenesis| |regulation of cell motility| |regulation of cellular localization| |regulation of cellular component biogenesis| |central nervous system development| |regulation of locomotion| |regulation of cellular component movement| |endoplasmic reticulum| |neuron differentiation| |response to drug| |regulation of protein localization| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |plasma membrane bounded cell projection organization| |cell projection organization| |negative regulation of multicellular organismal process| |lipid metabolic process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |regulation of response to stress| |generation of neurons| |response to oxygen-containing compound| |extracellular space| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |cell development| |regulation of immune system process| |cellular response to stress| |small molecule metabolic process| |tissue development| |regulation of transport| |extracellular region| </modal> \\ === CRISPR Data === <button type='default' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> No hits were found. </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 15954 * **<color #00a2e8>Expression level (log2 read counts)</color>**: -1.47 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='APOD Expression in NALM6 Cells: -1.47'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2025/12/10 20:19by 127.0.0.1